Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01571128 · ClinicalTrials.gov registry record · NA
Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)
A NA study, sponsored by New York University.
- Completed
- Registry status
- NA
- Development phase
- 1,215
- Enrollment target
NCT01571128: Completed NA study, sponsored by New York University.
NCT01571128 is a NA study that has completed, run by New York University. The registered enrollment target is 1,215 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01571128, a NA study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,215 participants
- Enrollment target
Study Summary
MP3 Youth is a pilot study to evaluate the feasibility and acceptability of a gender-specific combination HIV prevention package for youth (aged 15-24) in high burden settings. The study aims to pilot a combination package of gender-specific interventions in western Kenya in a mobile health delivery format using integrated services delivery.
Primary Outcome
* Coverage: The proportion of youth in the community who attend each mobile event (estimated from youth population denominator) * Enrollment: The number of participants who consent to being enrolled in the study during each mobile event. * Uptake: The number of participants who choose one or more components of their tailored combination package (and which components). * Intervention Acceptability: Satisfaction with mobile event services
Interventions
- OTHER Male-Specific Intervention Package
- OTHER Female-Specific Intervention Package
- DRUG Pre-Exposure Prophylaxis (Females)
- BEHAVIORAL Cash Transfer Cohort (Females)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,215 participants |
| Start Date | 2014-11 |
| Est. Completion | 2016-03-23 |
| Phase | NA |
What the finished NCT01571128 record still lists
NCT01571128 is an interventional study that assigns participants to a tested intervention. Its 1,215 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (13% lower).
The record links to 0 conditions, and to 4 interventions - of which Male-Specific Intervention Package is the first listed.
NCT01571128 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01571128 about?
NCT01571128 is a clinical study titled "Gender-Specific Combination HIV Prevention for Youth in High Burden Settings (MP3-Youth)". MP3 Youth is a pilot study to evaluate the feasibility and acceptability of a gender-specific combination HIV prevention package for youth (aged 15-24) in high burden settings. The study aims to pilot a combination package of gender-specific interventions in western Kenya in a mobile health delivery...
What is the current status of trial NCT01571128?
This trial is currently completed. It is a NA study. The enrollment target is 1,215 participants. The study started on 2014-11. Estimated completion is 2016-03-23.
What interventions are being tested in trial NCT01571128?
The interventions under investigation include: Male-Specific Intervention Package (OTHER), Female-Specific Intervention Package (OTHER), Pre-Exposure Prophylaxis (Females) (DRUG), Cash Transfer Cohort (Females) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01571128?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01571128's enrollment target sits among peer trials
1,215 83rd of 2000 higher than 1,918 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05827016 · 1,216 participants · Phase 3
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
- NCT06143956 · 1,217 participants · Phase 2
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
- NCT06921785 · 1,220 participants · Phase 3
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- NCT04267848 · 1,210 participants · Phase 3
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia